Clinical Trial Update: Rheumatoid Arthritis:Tolerance Induction by Mixed Chimerism [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial at Northwestern University evaluating tolerance induction by mixed chimerism for rheumatoid arthritis was terminated, with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Northwestern University | Conditions: Rheumatoid Arthritis | Phase 1 | Status: TERMINATED | Results posted: 2018-07-30